E‑Newsletter: Neuroimaging + machine learning can predict, with 96% accuracy, whether high-risk 6‑month-old babies will develop autism spectrum disorder (ASD) by age 2

By SharpBrains | June 27, 2017

_____ Time for Sharp­Brains’ June e‑newsletter, fea­tur­ing fas­ci­nat­ing sci­en­tif­ic find­ings, promis­ing assess­ments, ther­a­pies and brain health mon­i­tor­ing tools…and some fun opti­cal illu­sions :-) New research Study com­bines neu­roimag­ing with machine learn­ing to pre­dict, with 96% accu­ra­cy, whether high-risk 6‑month-old babies will devel­op autism spec­trum dis­or­der (ASD) by age 2 Cog­ni­tive Train­ing or Gingko Bilo­ba to pre­vent cog­ni­tive decline and…

Read More

Neurotech start-up Rythm raises $11 million more to develop and commercialize sleep-monitoring headband Dreem

By SharpBrains | June 20, 2017

— Dreem machine: Rythm rais­es $11 mil­lion and launch­es $500 sleep-mon­i­­tor­ing head­band (Ven­ture­Beat) “Found­ed out of France in 2014, Rythm is now based in San Fran­cis­co, where it has been work­ing toward bring­ing its Dreem machine head­band to market…In a nut­shell, Rythm touts itself as a neu­rotech­nol­o­gy com­pa­ny that’s set­ting out to “enhance” your sleep, 

Read More